Immuneering (IMRX) Return on Sales [ROS] (2020 - 2023)
Immuneering (IMRX) recorded Return on Sales [ROS] of -12328770.77% in Q3 2023, down 12294408.73 percentage points from -34362.04% a year earlier and down 12186224.82 percentage points from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Return on Sales [ROS] (2020 - 2023) Analysis & Trends
For FY2022, Immuneering reported Return on Sales [ROS] of -16325.77%, down 14696.61 percentage points from FY2021.
- Across earlier years, Return on Sales [ROS] came in at -1629.17% in FY2021 (-890.16 pp) and -739.01% in FY2020.
- The Q3 2023 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q2 2020.
- On a year-over-year basis, Return on Sales [ROS] has declined for ten consecutive quarters, with an average year-over-year change of -1947549.86 percentage points over the last eight quarters.
- Over the past five years, the year-over-year drop in Return on Sales [ROS] ranged from 460.60 percentage points (Q2 2021) to 12294408.73 percentage points (Q3 2023).
- Per Business Quant, the preceding three quarters came in at -142545.95% (Q2 2023), -40147.97% (Q1 2023) and -3073627.91% (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Immuneering | 249.34 Mn | -375.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -12,328,770.77% |
| Jun 30, 2023 | -142,545.95% |
| Mar 31, 2023 | -40,147.97% |
| Dec 31, 2022 | -3,073,627.91% |
| Sep 30, 2022 | -34,362.04% |
| Jun 30, 2022 | -12,334.43% |
| Mar 31, 2022 | -7,036.37% |
| Dec 31, 2021 | -5,863.02% |
| Sep 30, 2021 | -1,772.01% |
| Jun 30, 2021 | -1,210.67% |
| Mar 31, 2021 | -833.47% |
| Dec 31, 2020 | -877.56% |
| Sep 30, 2020 | -644.66% |
| Jun 30, 2020 | -750.08% |
API Access
Immuneering Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();